ArticleOncotarget2018

Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer.

Judith E Unterlass et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.